Statin use and cancer risk: a comprehensive review
Top Cited Papers
- 9 April 2010
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Drug Safety
- Vol. 9 (4), 603-621
- https://doi.org/10.1517/14740331003662620
Abstract
Importance of the field: HMG-CoA inhibitors (statins), a class of drugs that reduce cholesterol, are used to manage and prevent coronary heart disease. They are among the most commonly prescribed d...Keywords
This publication has 108 references indexed in Scilit:
- Effect of statins on a wide range of health outcomes: a cohort study validated by comparison with randomized trialsBritish Journal of Clinical Pharmacology, 2008
- Statin use and female reproductive organ cancer risk in a large population-based settingCancer Causes & Control, 2008
- Statin Use and Risk of Prostate Cancer: Results from a Population-based Epidemiologic StudyAmerican Journal of Epidemiology, 2008
- Statins and Cancer RiskThe American Journal of Medicine, 2008
- Statin use and prostate cancer risk in a large population-based settingCancer Causes & Control, 2008
- The Association Between Statins and Cancer Incidence in a Veterans PopulationJNCI Journal of the National Cancer Institute, 2008
- Post-diagnosis statin use and breast cancer recurrence in a prospective cohort study of early stage breast cancer survivorsBreast Cancer Research and Treatment, 2007
- Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studiesThe Lancet, 2007
- Statins and cancer preventionNature Reviews Cancer, 2005
- HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosisLeukemia, 2002